Cover Image

Efficacy and Safety of Monoclonal Antibody Against Calcitonin Gene-Related Peptide or Its Receptor for Migraine: A Systematic Review and Network Meta-analysis

Background: The optimal monoclonal antibody against calcitonin gene-related peptide (CGRP) for adult patients with migraine has yet to be determined. Therefore, we aimed to compare the effectiveness of different monoclonal antibodies against CGRP or its receptor for adult patients with migraine thro...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xing Wang (Author), Yuqi Chen (Author), Jinlei Song (Author), Chao You (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
by: Keisuke Suzuki, et al.
Published: (2024)

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies
by: Damiana Scuteri, et al.
Published: (2019)

Tolerability of calcitonin gene-related peptide monoclonal antibodies and other monoclonal antibodies in adults with concurrent migraine and other medical conditions
by: Kevin Weber, et al.
Published: (2024)

Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
by: María del Pilar Briceño-Casado, et al.
Published: (2020)

Network Meta-Analysis of Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine
by: Fang Xu, et al.
Published: (2019)

Placebo response with subcutaneous injections in calcitonin gene-related peptide receptor monoclonal antibody migraine preventative trials - A systematic review and meta-analysis
by: Sasikanth Gorantla, et al.
Published: (2022)

Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of New Anti-Migraine Drugs-Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
by: Danuta Szkutnik-Fiedler
Published: (2020)

Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison
by: Jiajie Lu, et al.
Published: (2021)

Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis
by: Yao-Yao Chen, et al.
Published: (2021)

Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
by: Eric R Ocheretyaner, et al.
Published: (2022)

Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
by: Shuchita Garg, et al.
Published: (2020)

Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
by: Wenfang Sun, et al.
Published: (2024)

Constipation as a possible predictor of poor treatment response in chronic migraine: A retrospective study of anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies and the impact of switching
by: Sena Uzun, et al.
Published: (2024)

Calcitonin Gene-Related Peptide (CGRP)-Targeted Treatments-New Therapeutic Technologies for Migraine
by: Linda Sangalli, et al.
Published: (2023)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
by: Casper Emil Christensen, et al.
Published: (2022)

Anticalcitonin gene-related peptide monoclonal antibodies: An overview
by: Jamir Pitton Rissardo, et al.
Published: (2020)

Monoclonal antibodies blocking CGRP for prevention of migraine
by: Alicja Maziarczyk, et al.
Published: (2023)

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
by: Bianca Raffaelli, et al.
Published: (2023)

Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence
by: Abubker Omaer, et al.
Published: (2024)

Different Monoclonal Antibodies in Myasthenia Gravis: A Bayesian Network Meta-Analysis
by: Zhaoming Song, et al.
Published: (2022)

The Mechanism of Calcitonin Gene-Related Peptide-Containing Nerve Innervation
by: Narumi Hashikawa-Hobara, et al.
Published: (2012)

Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
by: Aqfan Jamaluddin, et al.
Published: (2022)

Anti-CGRP monoclonal antibodies in the treatment of migraine in women: impact on menstrual relared migraine and algodysmenorrhea
by: Anna V. Berdnikova, et al.
Published: (2023)

Expression of calcitonin gene-related peptide and pulp sensitivity tests in irreversible pulpitis
by: Brenda Eréndida CASTILLO-SILVA, et al.

Calcitonin gene‐related peptide: An intra‐articular therapeutic target for TMJ disorders
by: Sabine M. Brouxhon, et al.
Published: (2022)

Calcitonin Gene-Related Peptide Downregulates Expression of Inducible Nitride Oxide Synthase and Caspase-3 after Intestinal Ischemia-Reperfusion Injury in Rats
by: Chih-Cheng Luo, et al.
Published: (2016)

Lafutidine Facilitates Calcitonin Gene-Related Peptide (CGRP) Nerve-Mediated Vasodilation via Vanilloid-1 Receptors in Rat Mesenteric Resistance Arteries
by: Tetsuhiro Sugiyama, et al.
Published: (2008)

Safety issues of monoclonal antibodies used in rheumatology
by: A. V. Philippova, et al.
Published: (2020)

Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study
by: Calogera Butera, et al.
Published: (2024)

Sensory neurons expressing calcitonin gene-related peptide α regulate adaptive thermogenesis and diet-induced obesity
by: Kuldeep Makwana, et al.
Published: (2021)

Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization
by: Cady Ryan J, et al.
Published: (2011)

Effects of NSAIDs on the Release of Calcitonin Gene-Related Peptide and Prostaglandin E2 from Rat Trigeminal Ganglia
by: Vittorio Vellani, et al.
Published: (2017)

Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors
by: Jian Jiang, et al.
Published: (2022)

Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
by: Kavisha R. Ulapane, et al.
Published: (2019)

Monoclonal Antibodies
Published: (2021)

Monoclonal Antibodies
by: Christian Klein (Ed.)
Published: (2018)

Role of Calcitonin Gene-Related Peptide in Nociceptive Modulationin Anterior Cingulate Cortex of Naïve Rats and Rats With Inflammatory Pain
by: Ke-Sai Hou, et al.
Published: (2020)

α−Calcitonin gene-related peptide inhibits autophagy and calpain systems and maintains the stability of neuromuscular junction in denervated muscles
by: Juliano Machado, et al.
Published: (2019)

Isolation of monoclonal antibodies targeting HLA-E/HIV-1 and SIV peptide complexes
by: D. Li, et al.
Published: (2019)

Effects of 17β-Estradiol and the Japanese Herbal Medicine Keishibukuryogan on the Release and Synthesis of Calcitonin Gene-Related Peptide in Ovariectomized Rats
by: Masamichi Noguchi, et al.
Published: (2003)